Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response
/in Chronic Leukemia, International Publications /von 2008-03-06 / Leukemia 2008 May;22(5):1007-17Brain tumor therapy by combined vaccination and antisense oligonucleotide delivery with nanoparticles
/in International Publications, Newcastle Disease Virus /von 2008-03-04 / J. Neuroimmunol. 2008 Mar;195(1-2):21-7Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour
/in Glioblastoma, International Publications /von 2008-03-04 / Radiother Oncol 2008 Mar;86(3):435-42The importance of schedule in whole body thermochemotherapy
/in Breast Cancer, Hyperthermia, International Publications /von 2008-03-01 / Int J Hyperthermia 2008 Mar;24(2):171-81Immunotherapy of hematological malignancies using dendritic cells
/in Dendritic Cells, International Publications, Malignant Lymphoma, Multiple Myeloma /von 2008-03-01 / Bull Cancer 2008 Mar;95(3):320-6
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution